U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07850141) titled 'Prospective Registry of Exposure to Gepotidacin (PREG)' on Sept. 11.
Brief Summary: The purpose of this study is to monitor pregnancies exposed to gepotidacin and to evaluate possible teratogenic effects or birthweight-lowering effects of this medication relative to the primary outcomes of major congenital malformations (MCMs) and small for gestational age (SGA), as well as to evaluate secondary maternal, fetal, and infant outcomes.
Study Start Date: Sept. 30
Study Type: OBSERVATIONAL
Condition:
Sexually Transmitted Diseases
Intervention:
OTHER: None (Observational study)
Not Applicable since Observational Study
OTHER: None (...